About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Anticoagulation Market Size is Predicted to reach USD 43,243.1 million by 2031

Anticoagulation Market

Anticoagulation Market Size, Share & Trends Analysis Report By Drug Class (Direct Anticoagulants (DOACS), Heparin and Low Molecular Weight (LMWH), Warfarin, Other Vitamin K Antagonists), By Disease Indication (Heart Attack, Stroke, Deep Vein Thrombosis/Pulmonary Embolism (PE), Mechanical Heart Valves (MHV)), By Route of Administration (ROA) (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54173DR
Study Period 2019-2031 CAGR 18.4%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 21,813.4 Million
Forecast Year 2031 Forecast Year Market Size USD 43243.1 Million
Largest Market North America Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Anticoagulation Market, By Drug Class (2021-2031)
    1. Direct Anticoagulants (DOACS)
    2. Heparin and Low Molecular Weight (LMWH)
    3. Warfarin
    4. Other Vitamin K Antagonists
  2. Anticoagulation Market, By Disease Indication (2021-2031)
    1. Heart Attack
    2. Stroke
    3. Deep Vein Thrombosis/Pulmonary Embolism (PE)
    4. Mechanical Heart Valves (MHV)
  3. Anticoagulation Market, By Route of Administration (ROA) (2021-2031)
    1. Oral
    2. Injectable
  4. Anticoagulation Market, By Distribution Channel (2021-2031)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    1. North America
      1. North America Anticoagulation Market, By Drug Class
        1. Direct Anticoagulants (DOACS)
          1. Heparin and Low Molecular Weight (LMWH)
            1. Warfarin
              1. Other Vitamin K Antagonists
              2. North America Anticoagulation Market, By Disease Indication
                1. Heart Attack
                  1. Stroke
                    1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                      1. Mechanical Heart Valves (MHV)
                      2. North America Anticoagulation Market, By Route of Administration (ROA)
                        1. Oral
                          1. Injectable
                          2. North America Anticoagulation Market, By Distribution Channel
                            1. Hospital Pharmacies
                              1. Retail Pharmacies
                                1. Online Pharmacies
                                2. U.S.
                                  1. U.S. Anticoagulation Market, By Drug Class
                                    1. Direct Anticoagulants (DOACS)
                                      1. Heparin and Low Molecular Weight (LMWH)
                                        1. Warfarin
                                          1. Other Vitamin K Antagonists
                                          2. U.S. Anticoagulation Market, By Disease Indication
                                            1. Heart Attack
                                              1. Stroke
                                                1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                  1. Mechanical Heart Valves (MHV)
                                                  2. U.S. Anticoagulation Market, By Route of Administration (ROA)
                                                    1. Oral
                                                      1. Injectable
                                                      2. U.S. Anticoagulation Market, By Distribution Channel
                                                        1. Hospital Pharmacies
                                                          1. Retail Pharmacies
                                                            1. Online Pharmacies
                                                          2. Canada
                                                        2. Europe
                                                          1. Europe Anticoagulation Market, By Drug Class
                                                            1. Direct Anticoagulants (DOACS)
                                                              1. Heparin and Low Molecular Weight (LMWH)
                                                                1. Warfarin
                                                                  1. Other Vitamin K Antagonists
                                                                  2. Europe Anticoagulation Market, By Disease Indication
                                                                    1. Heart Attack
                                                                      1. Stroke
                                                                        1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                          1. Mechanical Heart Valves (MHV)
                                                                          2. Europe Anticoagulation Market, By Route of Administration (ROA)
                                                                            1. Oral
                                                                              1. Injectable
                                                                              2. Europe Anticoagulation Market, By Distribution Channel
                                                                                1. Hospital Pharmacies
                                                                                  1. Retail Pharmacies
                                                                                    1. Online Pharmacies
                                                                                    2. U.K.
                                                                                      1. U.K. Anticoagulation Market, By Drug Class
                                                                                        1. Direct Anticoagulants (DOACS)
                                                                                          1. Heparin and Low Molecular Weight (LMWH)
                                                                                            1. Warfarin
                                                                                              1. Other Vitamin K Antagonists
                                                                                              2. U.K. Anticoagulation Market, By Disease Indication
                                                                                                1. Heart Attack
                                                                                                  1. Stroke
                                                                                                    1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                      1. Mechanical Heart Valves (MHV)
                                                                                                      2. U.K. Anticoagulation Market, By Route of Administration (ROA)
                                                                                                        1. Oral
                                                                                                          1. Injectable
                                                                                                          2. U.K. Anticoagulation Market, By Distribution Channel
                                                                                                            1. Hospital Pharmacies
                                                                                                              1. Retail Pharmacies
                                                                                                                1. Online Pharmacies
                                                                                                              2. Germany
                                                                                                              3. France
                                                                                                              4. Spain
                                                                                                              5. Italy
                                                                                                              6. Russia
                                                                                                              7. Nordic
                                                                                                              8. Benelux
                                                                                                              9. Rest of Europe
                                                                                                            2. APAC
                                                                                                              1. APAC Anticoagulation Market, By Drug Class
                                                                                                                1. Direct Anticoagulants (DOACS)
                                                                                                                  1. Heparin and Low Molecular Weight (LMWH)
                                                                                                                    1. Warfarin
                                                                                                                      1. Other Vitamin K Antagonists
                                                                                                                      2. APAC Anticoagulation Market, By Disease Indication
                                                                                                                        1. Heart Attack
                                                                                                                          1. Stroke
                                                                                                                            1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                                              1. Mechanical Heart Valves (MHV)
                                                                                                                              2. APAC Anticoagulation Market, By Route of Administration (ROA)
                                                                                                                                1. Oral
                                                                                                                                  1. Injectable
                                                                                                                                  2. APAC Anticoagulation Market, By Distribution Channel
                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                      1. Retail Pharmacies
                                                                                                                                        1. Online Pharmacies
                                                                                                                                        2. China
                                                                                                                                          1. China Anticoagulation Market, By Drug Class
                                                                                                                                            1. Direct Anticoagulants (DOACS)
                                                                                                                                              1. Heparin and Low Molecular Weight (LMWH)
                                                                                                                                                1. Warfarin
                                                                                                                                                  1. Other Vitamin K Antagonists
                                                                                                                                                  2. China Anticoagulation Market, By Disease Indication
                                                                                                                                                    1. Heart Attack
                                                                                                                                                      1. Stroke
                                                                                                                                                        1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                                                                          1. Mechanical Heart Valves (MHV)
                                                                                                                                                          2. China Anticoagulation Market, By Route of Administration (ROA)
                                                                                                                                                            1. Oral
                                                                                                                                                              1. Injectable
                                                                                                                                                              2. China Anticoagulation Market, By Distribution Channel
                                                                                                                                                                1. Hospital Pharmacies
                                                                                                                                                                  1. Retail Pharmacies
                                                                                                                                                                    1. Online Pharmacies
                                                                                                                                                                  2. Korea
                                                                                                                                                                  3. Japan
                                                                                                                                                                  4. India
                                                                                                                                                                  5. Australia
                                                                                                                                                                  6. Taiwan
                                                                                                                                                                  7. South East Asia
                                                                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                  1. Middle East and Africa Anticoagulation Market, By Drug Class
                                                                                                                                                                    1. Direct Anticoagulants (DOACS)
                                                                                                                                                                      1. Heparin and Low Molecular Weight (LMWH)
                                                                                                                                                                        1. Warfarin
                                                                                                                                                                          1. Other Vitamin K Antagonists
                                                                                                                                                                          2. Middle East and Africa Anticoagulation Market, By Disease Indication
                                                                                                                                                                            1. Heart Attack
                                                                                                                                                                              1. Stroke
                                                                                                                                                                                1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                                                                                                  1. Mechanical Heart Valves (MHV)
                                                                                                                                                                                  2. Middle East and Africa Anticoagulation Market, By Route of Administration (ROA)
                                                                                                                                                                                    1. Oral
                                                                                                                                                                                      1. Injectable
                                                                                                                                                                                      2. Middle East and Africa Anticoagulation Market, By Distribution Channel
                                                                                                                                                                                        1. Hospital Pharmacies
                                                                                                                                                                                          1. Retail Pharmacies
                                                                                                                                                                                            1. Online Pharmacies
                                                                                                                                                                                            2. UAE
                                                                                                                                                                                              1. UAE Anticoagulation Market, By Drug Class
                                                                                                                                                                                                1. Direct Anticoagulants (DOACS)
                                                                                                                                                                                                  1. Heparin and Low Molecular Weight (LMWH)
                                                                                                                                                                                                    1. Warfarin
                                                                                                                                                                                                      1. Other Vitamin K Antagonists
                                                                                                                                                                                                      2. UAE Anticoagulation Market, By Disease Indication
                                                                                                                                                                                                        1. Heart Attack
                                                                                                                                                                                                          1. Stroke
                                                                                                                                                                                                            1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                                                                                                                              1. Mechanical Heart Valves (MHV)
                                                                                                                                                                                                              2. UAE Anticoagulation Market, By Route of Administration (ROA)
                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                  1. Injectable
                                                                                                                                                                                                                  2. UAE Anticoagulation Market, By Distribution Channel
                                                                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                                                                      1. Retail Pharmacies
                                                                                                                                                                                                                        1. Online Pharmacies
                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                      1. LATAM Anticoagulation Market, By Drug Class
                                                                                                                                                                                                                        1. Direct Anticoagulants (DOACS)
                                                                                                                                                                                                                          1. Heparin and Low Molecular Weight (LMWH)
                                                                                                                                                                                                                            1. Warfarin
                                                                                                                                                                                                                              1. Other Vitamin K Antagonists
                                                                                                                                                                                                                              2. LATAM Anticoagulation Market, By Disease Indication
                                                                                                                                                                                                                                1. Heart Attack
                                                                                                                                                                                                                                  1. Stroke
                                                                                                                                                                                                                                    1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                                                                                                                                                      1. Mechanical Heart Valves (MHV)
                                                                                                                                                                                                                                      2. LATAM Anticoagulation Market, By Route of Administration (ROA)
                                                                                                                                                                                                                                        1. Oral
                                                                                                                                                                                                                                          1. Injectable
                                                                                                                                                                                                                                          2. LATAM Anticoagulation Market, By Distribution Channel
                                                                                                                                                                                                                                            1. Hospital Pharmacies
                                                                                                                                                                                                                                              1. Retail Pharmacies
                                                                                                                                                                                                                                                1. Online Pharmacies
                                                                                                                                                                                                                                                2. Brazil
                                                                                                                                                                                                                                                  1. Brazil Anticoagulation Market, By Drug Class
                                                                                                                                                                                                                                                    1. Direct Anticoagulants (DOACS)
                                                                                                                                                                                                                                                      1. Heparin and Low Molecular Weight (LMWH)
                                                                                                                                                                                                                                                        1. Warfarin
                                                                                                                                                                                                                                                          1. Other Vitamin K Antagonists
                                                                                                                                                                                                                                                          2. Brazil Anticoagulation Market, By Disease Indication
                                                                                                                                                                                                                                                            1. Heart Attack
                                                                                                                                                                                                                                                              1. Stroke
                                                                                                                                                                                                                                                                1. Deep Vein Thrombosis/Pulmonary Embolism (PE)
                                                                                                                                                                                                                                                                  1. Mechanical Heart Valves (MHV)
                                                                                                                                                                                                                                                                  2. Brazil Anticoagulation Market, By Route of Administration (ROA)
                                                                                                                                                                                                                                                                    1. Oral
                                                                                                                                                                                                                                                                      1. Injectable
                                                                                                                                                                                                                                                                      2. Brazil Anticoagulation Market, By Distribution Channel
                                                                                                                                                                                                                                                                        1. Hospital Pharmacies
                                                                                                                                                                                                                                                                          1. Retail Pharmacies
                                                                                                                                                                                                                                                                            1. Online Pharmacies
                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                      Related Reports

                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global inflight catering market size was valued at USD 12.24 billion in 2022. It is estimated to reach USD 32.13 billion by 2031, growing at a CAGR of 11.32% during the forecast period (2023–2031). The primary catalyst for growth in the inf
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                      Buy Now
                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                      The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                      Buy Now

                                                                                                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                                                                                                      © Copyright . All rights Reserved.